Skip to content

The effect of formalin on treatment of genital warts

Evaluation of efficacy of 5% formalin in treatment of female genital warts comparing to cryotherapy

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190714044200N1
Enrollment
80
Registered
2020-05-04
Start date
2020-02-20
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genital wart. Anogenital (venereal) warts

Interventions

Intervention 1: Intervention group: The patient uses the 5% formalin solution in the collodion base provided by the hospital pharmacist on the genital warts topically by an applicator daily for 10 min

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: All female patients with external genital warts referred for treatment with cryotherapy Patients should have at least 2 genital warts of the same size and appearance.

Exclusion criteria

Exclusion criteria: A wound or active skin disease other than wart at the treatment site Coagulation disorder The presence of other sexually transmitted diseases Immunodeficiency, such as HIV infection Using topical anti viral medications in the last two weeks Pregnancy and lactation Lesions in the internal genital system, such as vagina and cervix

Design outcomes

Primary

MeasureTime frame
Measurement of genital wart size in female patients. Timepoint: At the beginning of the study, one week later, two weeks later, three weeks later, four weeks after starting treatment. Method of measurement: caliper.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahsa Razeghi

Shiraz University of Medical Sciences

r_mahsa_2000@yahoo.com+98 71 3225 2618

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026